VERA- Vera Therapeutics, Inc.

Trade Summary

1 week ago, Fordyce Marshall, serving as PRESIDENT AND CEO at Vera Therapeutics, Inc. (VERA), sold 18,500 shares at $35.12 per share, for a total transaction value of $649,642.30. Following this transaction, Fordyce Marshall now holds 235,244 shares of VERA.

This sale represents a 7.29% decrease in Fordyce Marshall's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, September 2, 2026 and publicly disclosed via SEC Form 4 filing on Friday, September 4, 2026 at 4:15 PM ET, 2 days after the trade was made.

Vera Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.